Cargando…
Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
OBJECTIVES: The goal of our study was to evaluate the potential role of sTNF-RI as a biomarker of renal involvement in SLE patients and active SLE. METHODS: The study sample consisted of two cohorts. The discovery cohort included 16 SLE patients without renal involvement (non-LN), 60 lupus nephritis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035946/ https://www.ncbi.nlm.nih.gov/pubmed/36946374 http://dx.doi.org/10.1080/0886022X.2023.2174355 |
_version_ | 1784911530864672768 |
---|---|
author | Liu, Xin-ran Qi, Yuan-yuan Zhao, Ya-fei Cui, Yan Zhao, Zhan-zheng |
author_facet | Liu, Xin-ran Qi, Yuan-yuan Zhao, Ya-fei Cui, Yan Zhao, Zhan-zheng |
author_sort | Liu, Xin-ran |
collection | PubMed |
description | OBJECTIVES: The goal of our study was to evaluate the potential role of sTNF-RI as a biomarker of renal involvement in SLE patients and active SLE. METHODS: The study sample consisted of two cohorts. The discovery cohort included 16 SLE patients without renal involvement (non-LN), 60 lupus nephritis (LN) patients and 21 healthy controls (HCs) and the replication cohort included 18 SLE non-LN patients, 116 LN patients and 36 HCs. RESULTS: The sTNF-RI levels differed significantly in the discovery cohort. The plasma sTNF-RI levels were higher in LN patients than in non-LN patients (p = .009) and HCs (p = 4 × 10(−6)). Plasma sTNF-RI levels were significantly higher in non-LN patients than in HCs (p = .03). The finding was confirmed in independent replication cohort (LNs vs. non-LN, p = 4.053 × 10(−7); LNs vs. HCs, p = 2.395 × 10(−18); non-LN vs. HCs, p = 2.51 × 10(−4)). The plasma sTNF-RI levels were associated with disease activity, renal function in SLE patients and urine protein in LN patients. The multivariate analysis revealed that high sTNF-RI was an independent risk factor for renal involvement. The multivariate logistic regression results suggested that high TNF-RI, high systolic blood pressure, high serum creatinine, low C4 and positive anti-dsDNA were independent risks of active SLE patients. A nomogram was constructed based on the results of multivariate logistic regression analysis and it was practical in predicting the risk of the active SLE patients. Immunohistochemistry suggested that the expression of TNF-RI in the kidney was increased. CONCLUSIONS: Plasma sTNF-RI might be a good biomarker of renal involvement and disease activity in SLE patients. |
format | Online Article Text |
id | pubmed-10035946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-100359462023-03-24 Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients Liu, Xin-ran Qi, Yuan-yuan Zhao, Ya-fei Cui, Yan Zhao, Zhan-zheng Ren Fail Clinical Study OBJECTIVES: The goal of our study was to evaluate the potential role of sTNF-RI as a biomarker of renal involvement in SLE patients and active SLE. METHODS: The study sample consisted of two cohorts. The discovery cohort included 16 SLE patients without renal involvement (non-LN), 60 lupus nephritis (LN) patients and 21 healthy controls (HCs) and the replication cohort included 18 SLE non-LN patients, 116 LN patients and 36 HCs. RESULTS: The sTNF-RI levels differed significantly in the discovery cohort. The plasma sTNF-RI levels were higher in LN patients than in non-LN patients (p = .009) and HCs (p = 4 × 10(−6)). Plasma sTNF-RI levels were significantly higher in non-LN patients than in HCs (p = .03). The finding was confirmed in independent replication cohort (LNs vs. non-LN, p = 4.053 × 10(−7); LNs vs. HCs, p = 2.395 × 10(−18); non-LN vs. HCs, p = 2.51 × 10(−4)). The plasma sTNF-RI levels were associated with disease activity, renal function in SLE patients and urine protein in LN patients. The multivariate analysis revealed that high sTNF-RI was an independent risk factor for renal involvement. The multivariate logistic regression results suggested that high TNF-RI, high systolic blood pressure, high serum creatinine, low C4 and positive anti-dsDNA were independent risks of active SLE patients. A nomogram was constructed based on the results of multivariate logistic regression analysis and it was practical in predicting the risk of the active SLE patients. Immunohistochemistry suggested that the expression of TNF-RI in the kidney was increased. CONCLUSIONS: Plasma sTNF-RI might be a good biomarker of renal involvement and disease activity in SLE patients. Taylor & Francis 2023-03-22 /pmc/articles/PMC10035946/ /pubmed/36946374 http://dx.doi.org/10.1080/0886022X.2023.2174355 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Clinical Study Liu, Xin-ran Qi, Yuan-yuan Zhao, Ya-fei Cui, Yan Zhao, Zhan-zheng Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title | Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title_full | Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title_fullStr | Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title_full_unstemmed | Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title_short | Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
title_sort | plasma soluble tumor necrosis factor receptor i as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035946/ https://www.ncbi.nlm.nih.gov/pubmed/36946374 http://dx.doi.org/10.1080/0886022X.2023.2174355 |
work_keys_str_mv | AT liuxinran plasmasolubletumornecrosisfactorreceptoriasabiomarkeroflupusnephritisanddiseaseactivityinsystemiclupuserythematosuspatients AT qiyuanyuan plasmasolubletumornecrosisfactorreceptoriasabiomarkeroflupusnephritisanddiseaseactivityinsystemiclupuserythematosuspatients AT zhaoyafei plasmasolubletumornecrosisfactorreceptoriasabiomarkeroflupusnephritisanddiseaseactivityinsystemiclupuserythematosuspatients AT cuiyan plasmasolubletumornecrosisfactorreceptoriasabiomarkeroflupusnephritisanddiseaseactivityinsystemiclupuserythematosuspatients AT zhaozhanzheng plasmasolubletumornecrosisfactorreceptoriasabiomarkeroflupusnephritisanddiseaseactivityinsystemiclupuserythematosuspatients |